Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial | Zendy

Marı́a Elena Santolaya | Zendy; Ana Alvarez | Zendy; Mirta Acuña | Zendy; Carmen L. Avilés | Zendy; Carmen Salgado | Zendy; Juan Tordecilla | Zendy; Mónica Varas | Zendy; Marcela Venegas | Zendy; Milena Villarroel | Zendy; Marcela Zubieta | Zendy; Mauricio J. Farfán | Zendy; Verónica De la Maza | Zendy; Alejandra Vergara | Zendy; Romina Valenzuela | Zendy; Juan Pablo Torres | Zendy

Open Access

Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial

Author(s) -

Marı́a Elena Santolaya,

Ana Alvarez,

Mirta Acuña,

Carmen L. Avilés,

Carmen Salgado,

Juan Tordecilla,

Mónica Varas,

Marcela Venegas,

Milena Villarroel,

Marcela Zubieta,

Mauricio J. Farfán,

Verónica De la Maza,

Alejandra Vergara,

Romina Valenzuela,

Juan Pablo Torres

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky244

Subject(s) - medicine , febrile neutropenia , neutropenia , randomized controlled trial , clinical endpoint , chemotherapy

To compare the efficacy of pre-emptive versus empirical antifungal therapy in children with cancer, fever and neutropenia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore